DUBLIN--(BUSINESS WIRE)--The "Global Injectable Drug Delivery Market - Focus on Devices, Competitive Landscape and Country - Analysis and Forecast (2018-2025)" report has been added to ResearchAndMarkets.com's offering.
Global Injectable Drug Delivery Market to Reach $37.47 Billion in 2025
The injectable drug delivery devices market includes devices, such as auto-injectors, pen injectors and needle free injection technology. The market consists of various device products which can be used for various routes of administration, such as intravenous, subcutaneous/intradermal, intra-peritoneal, intra-muscular and others.
These devices are being used for the administration of various medications especially for the biological products and proteins, such as insulin. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.
The key players for the market are Antares Pharma, Becton Dickinson and Company, Baxter International AG, Elcam Medical, Eli-Lilly, Sanofi, Gerresheimer AG, PharmaJet, Injex Pharma, and Schott AG, among others.
Key Topics Covered:
1 Market Overview
2 Market Dynamics
3 Competitive Landscape
4 Industry Insights
5 Global Injectable Drug Delivery Market, By Device Type
6 Global Injectable Drug Delivery Market, By End User
7 Global Injectable Drug Delivery Market, By Route Of Administration
8 Global Injectable Drug Delivery Market, By Region
9 Company Profiles
- Alkermes Public Limited Company
- Antares Pharma
- Baxter International Inc
- Becton, Dickinson And Company
- Elcam Medical
- Eli-Lilly And Company
- Gerresheimer Ag
- Injex Pharma Gmbh
- Novo Nordisk
- Novartis Ag
- Pfizer, Inc
- Schott Ag
- Terumo Corporation
- Teva Pharmaceutical Industries Limited
- Vetter Pharma-Fertigung Gmbh & Co Kg
- West Pharmaceutical Services, Inc
- Ypsomed Holding Ag
For more information about this report visit https://www.researchandmarkets.com/research/smk48b/global_injectable?w=4